ARMK insider filing: 858 deferred stock units reported by director

Rhea-AI Filing Summary

Aramark (ARMK) reported a Form 4 for a director showing the acquisition of 858 fully vested deferred stock units on 10/10/2025 at $0, reflecting the director’s election to defer the cash retainer into units.

The units will be settled in common stock on the first day of the seventh month after the director leaves the board. Following the transaction, beneficial ownership was 60,192.32 shares direct and 12,475 shares indirect by a trust. The balance reflects an adjustment to a previously understated share count.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Creed Greg

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	858	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 60,192.32 shares (Direct); Common Stock — 12,475 shares (Indirect, By Trust)

Footnotes (1)

1. Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Balance reflects adjustment to previously understated number of shares.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Creed Greg

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/10/2025		A		858	A	$0(1)	60,192.32(2)	D
Common Stock								12,475	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.

2. Balance reflects adjustment to previously understated number of shares.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	10/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ARMK report on Form 4?

A director acquired 858 fully vested deferred stock units on 10/10/2025 at $0 by deferring a cash retainer.

How and when will the deferred units at Aramark (ARMK) be settled?

They will be settled in shares of common stock on the first day of the seventh month after the director departs the board.

What is the director’s beneficial ownership after the ARMK transaction?

60,192.32 shares direct and 12,475 shares indirect held by a trust.

What does the $0 price indicate for the ARMK deferred units?

It reflects that the units were issued from a cash retainer deferral, not a market purchase.

Did the filing note any corrections to prior share counts for ARMK?

Yes. It states the balance reflects an adjustment to a previously understated number of shares.

What is the reporting person’s relationship to Aramark (ARMK)?

The reporting person is a Director of Aramark.